Search

everythinglearnresearchcommunity

for

Search:↓

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Tamoxifen caused hair loss in a 52-year-old woman.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Some chemotherapy can cause permanent hair loss.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride causes harmful organ changes in female mice.